Yinzhong Ma
Overview
Explore the profile of Yinzhong Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin Q, Feng M, Zhang K, Mo Z, Liu Y, Ma Y, et al.
Eur J Pharmacol
. 2024 Dec;
989():177232.
PMID: 39734038
Cerebrovascular diseases are major global health issues, responsible for significant morbidity and mortality. Basigin (additionally called CD147 or EMMPRIN) is a glycosylated transmembrane protein that facilitates intercellular communication. Recent research...
2.
Feng Z, Fang C, Yu M, Wang Y, Abiola O, Lin J, et al.
Int Immunopharmacol
. 2024 Nov;
143(Pt 3):113586.
PMID: 39532019
Snake envenomation poses significant medical challenges, particularly in subtropical and tropical regions, with long-term impacts on neurovascular integrity and neuroinflammation remaining underexplored. This study investigates the effects of venom from...
3.
Feng Z, Fang C, Ma Y, Chang J
J Neuroinflammation
. 2024 Apr;
21(1):110.
PMID: 38678254
Obesity, a burgeoning global health issue, is increasingly recognized for its detrimental effects on the central nervous system, particularly concerning the integrity of the blood-brain barrier (BBB). This manuscript delves...
4.
He Q, Wang Y, Fang C, Feng Z, Yin M, Huang J, et al.
CNS Neurosci Ther
. 2024 Feb;
30(2):e14634.
PMID: 38379112
Ischemic stroke, accounting for the majority of stroke events, significantly contributes to global morbidity and mortality. Vascular recanalization therapies, namely intravenous thrombolysis and mechanical thrombectomy, have emerged as critical interventions,...
5.
Ji Y, Chen Y, Tan X, Huang X, Gao Q, Ma Y, et al.
CNS Neurosci Ther
. 2023 Oct;
30(4):e14483.
PMID: 37789643
Background: Reperfusion therapy after ischemic stroke often causes brain microvascular injury. However, the underlying mechanisms are unclear. Methods: Transcriptomic and proteomic analyses were performed on human cerebral microvascular endothelial cells...
6.
Ji Y, Gao Q, Ma Y, Wang F, Tan X, Song D, et al.
Pharmacol Res
. 2023 Mar;
190:106720.
PMID: 36893823
Rapid upregulation of matrix metalloproteinase 9 (MMP-9) leads to blood-brain barrier (BBB) breakdown following stroke, but no MMP-9 inhibitors have been approved in clinic largely due to their low specificities...
7.
He Q, Ma Y, Fang C, Deng Z, Wang F, Qu Y, et al.
Pharmacol Res
. 2023 Jan;
187:106641.
PMID: 36587812
Treatment of acute ischemic stroke with the recombinant tissue plasminogen activator (rtPA) is associated with increased blood-brain barrier (BBB) disruption and hemorrhagic transformation. Remote ischemic conditioning (RIC) has demonstrated neuroprotective...
8.
Ma Y, Chen Z, He Q, Guo Z, Yang Y, Liu F, et al.
Pharmacol Res
. 2022 Oct;
185:106482.
PMID: 36195305
Reperfusion therapy with recombinant tissue plasminogen activator (rtPA) or mechanical thrombectomy is the most effective treatment for ischemic stroke. However, a large proportion of stroke patients remain severely disabled even...
9.
Dai Z, Hu T, Su S, Liu J, Ma Y, Zhuo Y, et al.
Front Pharmacol
. 2022 Jun;
13:904857.
PMID: 35694256
Alzheimer's disease (AD) is one of the most common progressive neurodegenerative diseases, accompanied by global alterations in metabolic profiles. In the past 10 years, over hundreds of metabolomics studies have...
10.
Mo Z, Zeng Z, Liu Y, Zeng L, Fang J, Ma Y
Front Pharmacol
. 2022 Jun;
13:914537.
PMID: 35668927
Stroke is one of the leading causes of mortality, and survivors experience serious neurological and motor behavioral deficiencies. Following a cerebral ischemic event, substantial alterations in both cellular and molecular...